FDA
-
-
-
-
-
-
-
Illumina (ILMN) expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
-
-
-
-
-
-
-
Illumina announces expansion of TruSight Oncology portfolio
-
-
-
-
-
-
-
Grail bets big on flagship cancer test after spin-off from Illumina
-
-
-
-
-
-
-
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023
-
-
-
-
-
-
-
Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients Globally
-
-
-
-
-
-
-
GRAIL Presents Real-World Experience With The GalleriĀ® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting
-
-
-
-
-
-
-
Illumina (ILMN) Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

